跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ARX-BETAHISTINE betahistine dihydrochloride 16mg tablet blister pack
Approved
STANDARD
ARX-BETAHISTINE betahistine dihydrochloride 16mg tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Sep 27, 2025
Approval ID
ab67846c0584da1c
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
ab67846c0584da1c
Product Name
ARX-BETAHISTINE betahistine dihydrochloride 16mg tablet blister pack
Artg Id
504425
Artg Name
ARX-BETAHISTINE betahistine dihydrochloride 16mg tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2025-09-25
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Sep 27, 2025
Approval ID
ab67846c0584da1c
Type
Standard
Back to TGA Approvals
ARX-BETAHISTINE betahistine dihydrochloride 16mg tablet blister pack - TGA Drug Approval Details